Literature DB >> 718475

Treatment for patients with cerebral metastases.

W R Markesbery, W H Brooks, G D Gupta, A B Young.   

Abstract

To establish the effectiveness of treatment of patients with intracranial metastatic neoplasms, a retrospective study of survival of patients who had surgical excision, irradiation, or chemotherapy was compared with survival of patients who received no treatment. Our results indicate that although any form of therapy was superior to no treatment, no modality was clearly better than another. Furthermore, the prognosis for survival of patients with solitary lesions from a known primary was only slightly better than that of patients with numerous metastases. The prognosis was slightly improved when the cerebral lesion was detected before finding the primary site of origin. These observations should be considered when planning treatment for patients with brain metastases.

Entities:  

Mesh:

Year:  1978        PMID: 718475     DOI: 10.1001/archneur.1978.00500350058012

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

Review 1.  Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.

Authors:  Claudia Proto; Martina Imbimbo; Rosaria Gallucci; Angela Brissa; Diego Signorelli; Milena Vitali; Marianna Macerelli; Giulia Corrao; Monica Ganzinelli; Francesca Gabriella Greco; Marina Chiara Garassino; Giuseppe Lo Russo
Journal:  Transl Lung Cancer Res       Date:  2016-12

Review 2.  Ultrasound for drug and gene delivery to the brain.

Authors:  Kullervo Hynynen
Journal:  Adv Drug Deliv Rev       Date:  2008-04-06       Impact factor: 15.470

3.  Medullary metastasis of a malignant peripheral nerve sheath tumor: A case report.

Authors:  Tomohito Hagi; Tomoki Nakamura; Ayumu Yokoji; Akihiko Matsumine; Akihiro Sudo
Journal:  Oncol Lett       Date:  2016-07-15       Impact factor: 2.967

4.  Colorectal carcinoma and brain metastasis: distribution, treatment, and survival.

Authors:  M A Hammoud; I E McCutcheon; R Elsouki; D Schoppa; Y Z Patt
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

5.  Prognostic evaluation before operative extirpation and radiotherapy of solitary brain metastasis.

Authors:  L Pellettieri; U Sjölander; K E Jakobsson
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

6.  Gamma knife radiosurgery for brainstem metastasis.

Authors:  Tae Won Yoo; Eun Suk Park; Do Hoon Kwon; Chang Jin Kim
Journal:  J Korean Neurosurg Soc       Date:  2011-10-31

7.  Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer.

Authors:  Y Kudo; C Haymaker; J Zhang; A Reuben; D Y Duose; J Fujimoto; S Roy-Chowdhuri; L M Solis Soto; H Dejima; E R Parra; B Mino; R Abraham; N Ikeda; A Vaporcyan; D Gibbons; J Zhang; F F Lang; R Luthra; J J Lee; C Moran; J T Huse; H Kadara; I I Wistuba
Journal:  Ann Oncol       Date:  2019-09-01       Impact factor: 32.976

8.  Brain metastases from colon cancer.

Authors:  T L Cascino; J M Leavengood; N Kemeny; J B Posner
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

9.  Blindness as an initial presentation of rectal cancer with brain metastases.

Authors:  Tejinder Singh; K V Sajeevan; Ankit Jain; Ullas Batra; K S Saini; C T Satheesh; K C Lakshmaiah; K Govind Babu; D Lokanatha
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

Review 10.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.